{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:49:48Z","timestamp":1776487788357,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.lungcan.2008.07.018","type":"journal-article","created":{"date-parts":[[2008,9,20]],"date-time":"2008-09-20T08:40:24Z","timestamp":1221900024000},"page":"425-429","source":"Crossref","is-referenced-by-count":7,"title":["Interleukin-6-producing undifferentiated thymic carcinoma with neuroendocrine features"],"prefix":"10.1016","volume":"63","author":[{"given":"Masaru","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naofumi","family":"Shinagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Oizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Fugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.lungcan.2008.07.018_bib1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1916","article-title":"Interleukin-6: discovery of a pleiotropic cytokine","volume":"8","author":"Kishimoto","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lungcan.2008.07.018_bib2","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/cncr.22999","article-title":"Interleukin-6 and its receptor in cancer: implications for translational therapeutics","volume":"110","author":"Hong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2008.07.018_bib3","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/blood.V77.12.2794.2794","article-title":"Interleukin-6 is a prognostic factor in multiple myeloma","volume":"77","author":"Ludwig","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.lungcan.2008.07.018_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1200\/JCO.1995.13.3.575","article-title":"Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma","volume":"13","author":"Seymour","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.07.018_bib5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0002-9378(91)90582-C","article-title":"Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer","volume":"164","author":"Berek","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.lungcan.2008.07.018_bib6","first-page":"2702","article-title":"Serum interleukin-6 as a prognostic factor in patients with prostate cancer","volume":"6","author":"Nakashima","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2008.07.018_bib7","first-page":"649","article-title":"Serum levels of interleukin-6 as a prognostic factor in advanced non-small cell lung cancer","volume":"5","author":"De Vita","year":"1998","journal-title":"Oncol Rep"},{"key":"10.1016\/j.lungcan.2008.07.018_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2169\/internalmedicine.37.414","article-title":"Thymic carcinoma associated with a high serum level of interleukin 6 diagnosed through the evaluation for asymptomatic elevation of acute-phase reactants","volume":"37","author":"Ikeda","year":"1998","journal-title":"Intern Med"},{"key":"10.1016\/j.lungcan.2008.07.018_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2169\/internalmedicine.41.871","article-title":"Interleukin-6-producing thymic squamous cell carcinoma associated with Castleman's disease and nephritic syndrome","volume":"41","author":"Matsumura","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.lungcan.2008.07.018_bib10","series-title":"Cancer: principles and practice of oncology","first-page":"1019","article-title":"Neoplasms of the mediastinum","author":"Cameron","year":"2001"},{"key":"10.1016\/j.lungcan.2008.07.018_bib11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma. A clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2008.07.018_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0022-5223(94)70112-1","article-title":"Thymic carcinoma. Ten years\u2019 experience in twenty patients","volume":"107","author":"Hsu","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2008.07.018_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2559.2004.01796.x","article-title":"Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases","volume":"44","author":"Chalabreysse","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.lungcan.2008.07.018_bib14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/00000478-199809000-00003","article-title":"Neuroendocrine differentiation is a common feature of thymic carcinoma","volume":"22","author":"Lauriola","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lungcan.2008.07.018_bib15","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood.V74.4.1360.1360","article-title":"Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman's disease","volume":"74","author":"Yoshizaki","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.lungcan.2008.07.018_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.pas.0000155148.45423.b5","article-title":"Undifferentiated large cell carcinoma of the thymus associated with Castleman disease-like reaction: a distinctive type of thymic neoplasm characterized by an indolent behavior","volume":"29","author":"Nonaka","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lungcan.2008.07.018_bib17","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia","volume":"89","author":"Strassmann","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lungcan.2008.07.018_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/cyto.1998.0398","article-title":"Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer","volume":"11","author":"Martin","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.lungcan.2008.07.018_bib19","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","article-title":"Humanized anti-interleukin-6 receptor antibody treatment of Castleman disease","volume":"106","author":"Nishimoto","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lungcan.2008.07.018_bib20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1054\/bjoc.2001.1942","article-title":"IL-6 gene amplication and expression in human glioblastomas","volume":"85","author":"Tchirkov","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2008.07.018_bib21","doi-asserted-by":"crossref","first-page":"23159","DOI":"10.1074\/jbc.270.39.23159","article-title":"Modulation of interleukin-6-induced plasma protein secretion in hepatoma cells by p53 species","volume":"270","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2008.07.018_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<236::AID-IJC12>3.0.CO;2-R","article-title":"Differential regulation of IL-6 promoter activity in a human ovarian-tumor cell line transfected with various p53 mutants: involvement of AP-1","volume":"81","author":"Asschert","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2008.07.018_bib23","first-page":"932","article-title":"Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53","volume":"62","author":"Angelo","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2008.07.018_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/j.gastro.2006.10.037","article-title":"Sustained IL-6\/STAT3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing","volume":"132","author":"Isomoto","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lungcan.2008.07.018_bib25","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1172\/JCI31871","article-title":"Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas","volume":"117","author":"Gao","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lungcan.2008.07.018_bib26","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00000478-199708000-00008","article-title":"Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity","volume":"21","author":"Dorfman","year":"1997","journal-title":"Am J Surg Pathol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208004157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208004157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T11:36:44Z","timestamp":1588937804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500208004157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0169500208004157"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2008.07.018","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}